Literature DB >> 1627140

N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells.

R F Minchin1, P T Reeves, C H Teitel, M E McManus, B Mojarrabi, K F Ilett, F F Kadlubar.   

Abstract

Human monomorphic and polymorphic arylamine acetyltransferases (EC 2.3.1.5) were expressed in monkey kidney COS-1 cells and used to study the N- and O-acetylation of a number of carcinogenic amines and their N-hydroxy metabolites. The monomorphic enzyme N-acetylated the aromatic amines, 2-aminofluorene and 4-aminobiphenyl, and also O-acetylated their N-hydroxy derivatives. None of the food-derived heterocyclic amines (Glu-P-1, PhIP, IQ, MeIQx) were substrates and their N-hydroxy metabolites were poorly O-acetylated by this isozyme. By contrast, the polymorphic acetyltransferase catalyzed the N-acetylation of both aromatic amines, and to a lesser extent, Glu-P-1 and PhIP. However, all six N-hydroxy amine substrates were readily O-acetylated to form DNA-bound adducts by the polymorphic isozyme. These data suggest that, for the heterocyclic amine carcinogens, rapid acetylator individuals will be predisposed to their genotoxicity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627140     DOI: 10.1016/0006-291x(92)91703-s

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

1.  UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans.

Authors:  Hugo Girard; Lesley M Butler; Lyne Villeneuve; Robert C Millikan; Rashmi Sinha; Robert S Sandler; Chantal Guillemette
Journal:  Mutat Res       Date:  2008-07-16       Impact factor: 2.433

Review 2.  DNA adducts: Formation, biological effects, and new biospecimens for mass spectrometric measurements in humans.

Authors:  Byeong Hwa Yun; Jingshu Guo; Medjda Bellamri; Robert J Turesky
Journal:  Mass Spectrom Rev       Date:  2018-06-11       Impact factor: 10.946

3.  N-Acetyltransferase polymorphism and human cancer risk.

Authors:  X Yang; T Takeshita; K Morimoto
Journal:  Environ Health Prev Med       Date:  2000-01       Impact factor: 3.674

Review 4.  Differential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic amines.

Authors:  Wen-Chi L Chang; Terry V Zenser; Harry S Cooper; Margie L Clapper
Journal:  Cancer Lett       Date:  2013-02-13       Impact factor: 8.679

5.  Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.

Authors:  Mark A Doll; Yu Zang; Timothy Moeller; David W Hein
Journal:  J Pharmacol Exp Ther       Date:  2010-04-29       Impact factor: 4.030

6.  Meat consumption, heterocyclic amines and colorectal cancer risk: the Multiethnic Cohort Study.

Authors:  Nicholas J Ollberding; Lynne R Wilkens; Brian E Henderson; Laurence N Kolonel; Loïc Le Marchand
Journal:  Int J Cancer       Date:  2012-04-05       Impact factor: 7.396

7.  Polymorphisms in xenobiotic metabolizing genes, intakes of heterocyclic amines and red meat, and postmenopausal breast cancer.

Authors:  Hae-Jeung Lee; Kana Wu; David G Cox; David Hunter; Susan E Hankinson; Walter C Willett; Rashmi Sinha; Eunyoung Cho
Journal:  Nutr Cancer       Date:  2013-10-07       Impact factor: 2.900

8.  Biomonitoring of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its carcinogenic metabolites in urine.

Authors:  Jean-Marie Fede; Anup P Thakur; Nigel J Gooderham; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

9.  Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases.

Authors:  D W Hein; T D Rustan; R J Ferguson; M A Doll; K Gray
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Racial differences in clinical and pathological associations with PhIP-DNA adducts in prostate.

Authors:  Deliang Tang; Jason J Liu; Cathryn H Bock; Christine Neslund-Dudas; Andrew Rundle; Adnan T Savera; James J Yang; Nora L Nock; Benjamin A Rybicki
Journal:  Int J Cancer       Date:  2007-09-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.